Keynote Conference
Samuel Yamshon, MDWeill Cornell Medicine/NewYork-Presbyterian
Thomas Marron, MD, PhDThe Tisch Cancer Institute at Mount Sinai
Medical Spotlight
Rahul Banerjee, MD, FACPFred Hutchinson Cancer Center
Sam Brondfield, MD, MAUCSF Helen Diller FamilyComprehensive Cancer Center
Jennifer Effie Amengual, MDColumbia University Hebert IrvingComprehensive Cancer Center
Danielle E. Hammond, MD, FRCP(C)The University of TexasMD Anderson Cancer Center
Amanda Nizam, MDCleveland Clinic
Atezolizumab Plus Chemo Misses Mark in Early-Relapsing Unresectable TNBC
Olaparib/Durvalumab/Fulvestrant Combo Meets PFS End Point in HRR-Altered or MSI ER+/HER2– Breast Cancer
Frontline Atezolizumab Plus Sacituzumab Govitecan Elicits Responses in PD-L1+ Advanced TNBC
Time to Bladder Cancer Treatment Is Similar Among Black and White Patients, But Other Disparities Persist